Table 1. APOE genotypes in all-cause ESRD patients and healthy controls and odds ratios (95% confidence interval) for all-cause ESRD for the +APOE2 or +APOE4 allele carriers vs. APOE3E3 homozygotes.
Cases N (%) | Controls N (%) | Odds ratio (95% CI | |
---|---|---|---|
+ APOE2 allele | 158 (15.9%) | 760 (12.2%) | 1.37 (1.13-1.67) |
APOE3E3 | 625 (62.8%) | 4128 (66.1%) | 1.0 (reference) |
+ APOE4 allele | 195 (19.6%) | 1224 (21.7%) | 1.05 (0.88-1.26) |